confirmed the oncogenic role of METTL3 in CRC by inducing lncRNA LBX2-AS1 m6A hypermethylation to enhance its mRNA stability, resulting in significant increases in LBX2-AS1 mRNA in CRC cells. The gene discussed is METTL3; the disease is colorectal carcinoma.